Sign In
Buy ALNA
$0.0270
+0 (+0%)
At Close: Feb 07, 2023
Allena Pharmaceuticals to Present at 2020 Wedbush PacGrow Healthcare Virtual Conference
12:00pm, Tuesday, 04'th Aug 2020
NEWTON, Mass., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral e
Contrasting Cellectis (NASDAQ:CLLS) & Allena Pharmaceuticals (NASDAQ:ALNA)
01:36am, Monday, 03'rd Aug 2020
Allena Pharmaceuticals (NASDAQ:ALNA) and Cellectis (NASDAQ:CLLS) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of
Allena Pharmaceuticals Increases Previously Announced Bought Deal to $6.7 Million
12:48am, Tuesday, 28'th Jul 2020
NEWTON, Mass., July 27, 2020 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 27)
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT)
Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE: BIO)...
Allena Pharmaceuticals Announces $5.0 Million Bought Deal Offering
08:53pm, Monday, 27'th Jul 2020
NEWTON, Mass., July 27, 2020 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral
3 “Strong Buy” Penny Stocks That Could Rally to $10 (Or More)
07:27pm, Thursday, 16'th Jul 2020
Since June 8, stocks have been moving, but they’ve been going in a sideways direction. While this movement combined with low expectations for Q2 earnings is concerning, one Wall Street pro believes
Hedge Funds Nibbling On Allena Pharmaceuticals, Inc. (ALNA)
11:12pm, Monday, 15'th Jun 2020
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Ev
Allena Pharmaceuticals Announces $15.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
05:15pm, Wednesday, 03'rd Jun 2020
Allena Pharmaceuticals, Inc. (ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and sever
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 1) * Adaptimmune Therapeutics PLC - ADR (NASDAQ: ADAP) *
Allena Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference
12:00pm, Tuesday, 26'th May 2020
NEWTON, Mass., May 26, 2020 -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class,.
Allena Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Update
12:00pm, Wednesday, 13'th May 2020
Allena Pharmaceuticals, Inc. (ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe
Allena Pharmaceuticals, Inc. (ALNA) Moves to Strong Buy: Rationale Behind the Upgrade
04:00pm, Wednesday, 22'nd Apr 2020
Allena Pharmaceuticals, Inc. (ALNA) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near
Allena Pharmaceuticals (NASDAQ:ALNA) and Allogene Therapeutics (NASDAQ:ALLO) Critical Comparison
05:54am, Friday, 10'th Apr 2020
Allena Pharmaceuticals (NASDAQ:ALNA) and Allogene Therapeutics (NASDAQ:ALLO) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of the
Allena Pharmaceuticals, Inc. (ALNA) Upgraded to Buy: Here's Why
04:00pm, Wednesday, 18'th Mar 2020
Allena Pharmaceuticals, Inc. (ALNA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).
Allena Pharmaceuticals (ALNA) Gets a Buy Rating from B.Riley FBR
11:11am, Wednesday, 18'th Mar 2020
In a report released today, Mayank Mamtani from B.Riley FBR reiterated a Buy rating on Allena Pharmaceuticals (ALNA), with a price target of $4.00. The
